Mice harboring the human <i>SLC30A8</i> R138X loss-of-function mutation have increased insulin secretory capacity
Sandra Kleiner(Regeneron (United States)), Jesper Gromada(Regeneron (United States))
Cited by 63
Related Papers
Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways
|Diabetes|2006|491
Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition
|Proceedings of the National Academy of Sciences|2017|20